These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8889911)

  • 21. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA
    J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine oxidase inhibitors for depression.
    Med Lett Drugs Ther; 1980 Jul; 22(14):58-60. PubMed ID: 7382910
    [No Abstract]   [Full Text] [Related]  

  • 25. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologically active amines in fermented and non-fermented commercial soybean products from the Spanish market.
    Toro-Funes N; Bosch-Fuste J; Latorre-Moratalla ML; Veciana-Nogués MT; Vidal-Carou MC
    Food Chem; 2015 Apr; 173():1119-24. PubMed ID: 25466133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyramine content of preserved and fermented foods or condiments of Far Eastern cuisine.
    Da Prada M; Zürcher G
    Psychopharmacology (Berl); 1992; 106 Suppl():S32-4. PubMed ID: 1546136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer.
    Tailor SA; Shulman KI; Walker SE; Moss J; Gardner D
    J Clin Psychopharmacol; 1994 Feb; 14(1):5-14. PubMed ID: 8151003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
    Larsen JK; Krogh-Nielsen L; Brøsen K
    Ugeskr Laeger; 2015 Dec; 177(52):V06150499. PubMed ID: 26692222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine oxidase inhibitors: a new generation.
    Robinson DS
    Psychopharmacol Bull; 2002; 36(3):124-38. PubMed ID: 12473970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.
    Sjöqvist F
    Proc R Soc Med; 1965 Nov; 58(11 Part 2):967-78. PubMed ID: 4952963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease.
    White WB; Salzman P; Schwid SR;
    Hypertension; 2008 Sep; 52(3):587-93. PubMed ID: 18678789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibitor update. Potential adverse food and drug interactions.
    Lippman SB; Nash K
    Drug Saf; 1990; 5(3):195-204. PubMed ID: 2190595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL; Sunderland T; Cohen RM
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.
    Antal EJ; Hendershot PE; Batts DH; Sheu WP; Hopkins NK; Donaldson KM
    J Clin Pharmacol; 2001 May; 41(5):552-62. PubMed ID: 11361052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoamine oxidase inhibitors and food precautions. A comparison of utilization in Belgian psychiatric education institutes and current findings in the literature].
    Mallet L; Schittecatte M
    Acta Psychiatr Belg; 1996; 96(2):74-100. PubMed ID: 8693949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attempts to attenuate the 'cheese effect'. Combined drug therapy in depressive illness.
    Pare CM; Al Mousawi M; Sandler M; Glover V
    J Affect Disord; 1985 Sep; 9(2):137-41. PubMed ID: 2932486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MONOAMINE OXIDASE INHIBITORS: AUGMENTATION OF PRESSOR EFFECTS OF PERORAL TYRAMINE.
    TEDESCHI DH; FELLOWS EJ
    Science; 1964 Jun; 144(3623):1225-6. PubMed ID: 14150325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reexamining the dietary restrictions with procarbazine (an MAOI).
    Maxwell MB
    Cancer Nurs; 1980 Dec; 3(6):451-7. PubMed ID: 6903477
    [No Abstract]   [Full Text] [Related]  

  • 40. Dietary consideration in MAO inhibitor regimens.
    McCabe B; Tsuang MT
    J Clin Psychiatry; 1982 May; 43(5):178-81. PubMed ID: 7076627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.